These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29558894)

  • 61. Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation.
    Memirie ST; Desalegn H; Naizgi M; Nigus M; Taddesse L; Tadesse Y; Tessema F; Zelalem M; Girma T
    Cost Eff Resour Alloc; 2020; 18():23. PubMed ID: 32704237
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
    Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
    [No Abstract]   [Full Text] [Related]  

  • 63. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
    Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
    Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
    Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
    Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil.
    Aceituno D; Razzouk D; Jin H; Pennington M; Gadelha A; Bressan R; Noto C; Crossley N; Prina M;
    Epidemiol Psychiatr Sci; 2024 Apr; 33():e21. PubMed ID: 38576239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
    Fung A; Horton S; Zabih V; Denburg A; Gupta S
    BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review.
    Goh SP; Ong SC; Chan JE
    BMC Cancer; 2024 Mar; 24(1):316. PubMed ID: 38454347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review.
    Icanervilia AV; van der Schans J; Cao Q; de Carvalho AC; Cordova-Pozo K; At Thobari J; Postma MJ; van Asselt AD
    J Glob Health; 2022 Jul; 12():04048. PubMed ID: 35837900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia.
    Schmit N; Nayagam S; Lemoine M; Ndow G; Shimakawa Y; Thursz MR; Hallett TB
    J Glob Health; 2023 Jan; 13():04004. PubMed ID: 36655869
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review.
    Gurav YK; Bagepally BS; Thakkinstian A; Chaikledkaew U; Thavorncharoensap M
    Indian J Med Res; 2022 Sep; 156(3):388-410. PubMed ID: 36629171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of Humanitarian Pediatric Cardiac Surgery Programs in Low- and Middle-Income Countries.
    Cardarelli M; Vaikunth S; Mills K; DiSessa T; Molloy F; Sauter E; Bowtell K; Rivera R; Shin AY; Novick W
    JAMA Netw Open; 2018 Nov; 1(7):e184707. PubMed ID: 30646368
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Economic evaluation of implementing a decentralised Hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India.
    Muniyandi M; Tyagi K; Singh M; Prakash V; Karikalan N; Senthilkumar S; Karthikeyan S; Krishnan R; Rajsekar K; Shanmugam V; Selvavinayagam TS
    Trop Med Int Health; 2021 Mar; 26(3):374-384. PubMed ID: 33190357
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Economic evaluation guidelines in low- and middle-income countries: a systematic review.
    Daccache C; Rizk R; Dahham J; Evers SMAA; Hiligsmann M; Karam R
    Int J Technol Assess Health Care; 2021 Dec; 38(1):e1. PubMed ID: 34931601
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cost-effectiveness of hypertension management in low-income and middle-income countries: a review.
    Kostova D; Spencer G; Moran AE; Cobb LK; Husain MJ; Datta BK; Matsushita K; Nugent R
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32912853
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).
    Beutels P
    Health Econ; 2001 Dec; 10(8):751-74. PubMed ID: 11747055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
    Mac S; da Silva SR; Sander B
    PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A systematic review of vaccine preventable disease surveillance cost studies.
    Erondu NA; Ferland L; Haile BH; Abimbola T
    Vaccine; 2019 Apr; 37(17):2311-2321. PubMed ID: 30902482
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost and cost-effectiveness analysis of treatment for child undernutrition in low- and middle-income countries: A systematic review.
    Njuguna RG; Berkley JA; Jemutai J
    Wellcome Open Res; 2020; 5():62. PubMed ID: 33102783
    [No Abstract]   [Full Text] [Related]  

  • 80. Is Artificial Intelligence the Cost-Saving Lens to Diabetic Retinopathy Screening in Low- and Middle-Income Countries?
    Rizvi A; Rizvi F; Lalakia P; Hyman L; Frasso R; Sztandera L; Das AV
    Cureus; 2023 Sep; 15(9):e45539. PubMed ID: 37868419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.